Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TPT1 pseudogene 13 (TPT1P13) is a non-protein-coding genomic segment resembling the parental TPT1 gene, which encodes translationally-controlled tumor protein (TCTP). Pseudogenes such as TPT1P13 do not produce functional proteins but may have subtle regulatory effects on the parental gene's function at the RNA level—such as acting as miRNA decoys, antisense RNAs, or competing endogenous RNAs (ceRNAs)—though no specific function or disease association is documented for TPT1P13 itself. TPT1P13 should not be considered a standard therapeutic target or receptor. If information is required on TPT1 itself, the protein-coding functional TPT1 (TCTP, tumor protein, translationally-controlled 1) gene is widely studied for roles in cell growth, apoptosis, cancer, and other pathways.
None for TPT1P13. No established drug mechanisms target this pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TPT1 pseudogene 13 (TPT1P13).